close

Clinical Trials

1 2 3 219
Number of results: 4362

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2018-10-19 apceth-201 acute graft-versus-host disease (aGvHD) preclinical apceth (Germany) Transplantation
2018-10-16 BI-1607 (anti FcgammaRllB antibody/anti-PD1 antibody) solid tumors preclinical BioInvent (Sweden) Cancer - Oncology
2018-10-16 anti FcgammaRllB antibody/anti-PD1 antibody program solid tumors preclinical BioInvent (Sweden) Cancer - Oncology
2018-10-16 BI-1808 solid tumors preclinical BioInvent (Sweden) Cancer - Oncology
2018-10-15 BPS-804 (setrusumab) osteogenesis imperfecta (OI) 2b Mereo Biopharma (UK) Bone diseases - Metabolic diseases - Rare diseases
2018-10-15 KB103 (replication defective herpes simplex type 1 virus (HSV-1) vector expressing human COL7 protein) dystrophic epidermolysis bullosa 1-2 Krystal Biotech (USA - PA) Rare diseases - Genetic diseases - Dermatological diseases
2018-10-15 ARO-ANG3 dyslipidemia 1 Arrowhead Pharmaceuticals (USA - CA) Metabolic diseases
2018-10-12 zanubrutinib - BGB-3111 chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenstöm's macroglobulinemia 1 BeiGene (China) Cancer - Oncology
2018-10-12 evobrutinib - M2951 relapsing multiple sclerosis (RMS) 2 Merck KGaA (Germany) Autoimmune diseases - Neurodegenerative diseases
2018-10-12 Opdivo® (nivolumab) relapsed small cell lung cancer 3 BMS (USA - NY) Cancer - Oncology
2018-10-12 CMB305 and atezolizumab soft tissue sarcoma, locally advanced, relapsed, or metastatic NY-ESO-1+ synovial sarcoma or myxoid/round-cell liposarcoma. 2 Immune Design (USA - MA) Cancer - Oncology
2018-10-12 CMB305 (LV305 and G305) - dendritic-cell targeting, lentiviral vector encoding the NY-ESO-1 gene05 synovial sarcoma 3 Immune Design (USA - MA) Cancer - Oncology
2018-10-11 lifileucel - LN-144 metastatic melanoma 2 Lion Biotechnologies (USA - CA), now Iovance Biotherapeutics (USA - CA) Cancer - Oncology
2018-10-06 LOXO-292 RET-fusion non-small cell lung cancer (NSCLC), medullary thyroid cancer (MTC) and other tumors with increased RET activity 1-2 Loxo Oncology (USA - CT) Cancer - Oncology
2018-10-06 Translarna™ (ataluren) Duchenne muscular dystrophy observational PTC Therapeutics (USA - NJ) Rare diseases - Genetic diseases - Neuromuscular diseases
2018-10-06 Spinraza® (nusinersen) spinal muscular atrophy (SMA) 2 Biogen (USA - MA) Rare diseases - Genetic diseases - Neuromuscular diseases
2018-10-05 AT132 X-Linked Myotubular Myopathy (XLMTM) 1-2 Audentes Therapeutics (USA - CA) Rare diseases - Genetic diseases - Neuromuscular diseases
2018-10-05 Orbactiv™ (oritavancin) infections due to presumed or confirmed gram-positive bacteria observational Melinta Therapeutics (USA - CT) Infectious diseases
2018-10-04 birinapant and pembrozilumab treatment-resistant solid tumours 1-2 Medivir (Sweden) Cancer - Oncology
2018-10-03 risdiplam - RG7916/RO7034067 type 1spinal muscular atrophy (SMA) 2 PTC Therapeutics (USA - NJ) Roche (Switzerland) Rare diseases - Genetic diseases - Neuromuscular diseases